FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169746680> ?p ?o ?g. }

• W2169746680 endingPage "740" @default.
• W2169746680 startingPage "734" @default.
• W2169746680 abstract "BackgroundThe clinical relevance of transforming growth factor-beta (TGF-β)-signalling pathway in breast carcinomas (BCs) remained elusive. This study aimed to evaluate the prognostic value of TGF-β1 and transforming growth factor-beta type II receptor (TGF-βRII) expression levels in tumour cells and their association with the established biomarkers in BC.Patients and methodsIn 324 BC from patients with long-term follow-up, the TGF-β1 and TGF-βRII transcript and protein expression levels were assessed.ResultsTGF-β1 and TGF-βRII down-expression was significantly associated with BC. Negative TGF-β1 and TGF-βRII protein status was associated with the development of distant metastasis (P = 0.003 and P = 0.029, respectively). In multivariate analysis, TGF-β1-positive tumours were associated with increased disease-free survival (DFS) [hazard ratio (HR) = 0.489, P = 0.003]. TGF-βRII positivity was an independent prognostic factor for DFS (HR = 0.439, P = 0.001) and overall survival (OS) (HR = 0.409, P = 0.003) in human epidermal growth factor receptor-2 (HER2)-negative patients. Absence of TGF-β1 and TGF-βRII proteins in breast tumour cells was significantly associated with metastasis development.ConclusionsTo the best of our knowledge, this is the first report indicating the relevance of HER2 status in discriminating TGF-βRII as a prognostic marker for DFS and OS in human BC. These data indicate that TGF-βRII protein analysis in tumour cells could be introduced in clinical practice as additional prognostic biomarker in HER2-negative BC." @default.
• W2169746680 created "2016-06-24" @default.
• W2169746680 creator A5010503158 @default.
• W2169746680 creator A5015888366 @default.
• W2169746680 creator A5036301488 @default.
• W2169746680 creator A5052753948 @default.
• W2169746680 creator A5055383027 @default.
• W2169746680 creator A5056902949 @default.
• W2169746680 creator A5080264503 @default.
• W2169746680 creator A5084997825 @default.
• W2169746680 date "2010-04-01" @default.
• W2169746680 modified "2023-10-14" @default.
• W2169746680 title "Absence of transforming growth factor-β type II receptor is associated with poorer prognosis in HER2-negative breast tumours" @default.
• W2169746680 cites W1965751280 @default.
• W2169746680 cites W1971884763 @default.
• W2169746680 cites W1984162437 @default.
• W2169746680 cites W1997508119 @default.
• W2169746680 cites W2003325719 @default.
• W2169746680 cites W2008537833 @default.
• W2169746680 cites W2016920291 @default.
• W2169746680 cites W2028476252 @default.
• W2169746680 cites W2030650310 @default.
• W2169746680 cites W2048654496 @default.
• W2169746680 cites W2054541484 @default.
• W2169746680 cites W2066973526 @default.
• W2169746680 cites W2078969771 @default.
• W2169746680 cites W2100816986 @default.
• W2169746680 cites W2108244474 @default.
• W2169746680 cites W2112194601 @default.
• W2169746680 cites W2129115386 @default.
• W2169746680 cites W2130870648 @default.
• W2169746680 cites W2133108603 @default.
• W2169746680 cites W2136280424 @default.
• W2169746680 cites W2140905796 @default.
• W2169746680 cites W2146078790 @default.
• W2169746680 cites W2163032998 @default.
• W2169746680 cites W2170856503 @default.
• W2169746680 doi "https://doi.org/10.1093/annonc/mdp518" @default.
• W2169746680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19914962" @default.
• W2169746680 hasPublicationYear "2010" @default.
• W2169746680 type Work @default.
• W2169746680 sameAs 2169746680 @default.
• W2169746680 citedByCount "22" @default.
• W2169746680 countsByYear W21697466802012 @default.
• W2169746680 countsByYear W21697466802013 @default.
• W2169746680 countsByYear W21697466802014 @default.
• W2169746680 countsByYear W21697466802015 @default.
• W2169746680 countsByYear W21697466802016 @default.
• W2169746680 countsByYear W21697466802017 @default.
• W2169746680 countsByYear W21697466802019 @default.
• W2169746680 countsByYear W21697466802021 @default.
• W2169746680 countsByYear W21697466802022 @default.
• W2169746680 crossrefType "journal-article" @default.
• W2169746680 hasAuthorship W2169746680A5010503158 @default.
• W2169746680 hasAuthorship W2169746680A5015888366 @default.
• W2169746680 hasAuthorship W2169746680A5036301488 @default.
• W2169746680 hasAuthorship W2169746680A5052753948 @default.
• W2169746680 hasAuthorship W2169746680A5055383027 @default.
• W2169746680 hasAuthorship W2169746680A5056902949 @default.
• W2169746680 hasAuthorship W2169746680A5080264503 @default.
• W2169746680 hasAuthorship W2169746680A5084997825 @default.
• W2169746680 hasBestOaLocation W21697466801 @default.
• W2169746680 hasConcept C118131993 @default.
• W2169746680 hasConcept C121608353 @default.
• W2169746680 hasConcept C125555471 @default.
• W2169746680 hasConcept C126322002 @default.
• W2169746680 hasConcept C143998085 @default.
• W2169746680 hasConcept C170493617 @default.
• W2169746680 hasConcept C207103383 @default.
• W2169746680 hasConcept C2775960820 @default.
• W2169746680 hasConcept C2781197716 @default.
• W2169746680 hasConcept C2908728163 @default.
• W2169746680 hasConcept C44249647 @default.
• W2169746680 hasConcept C502942594 @default.
• W2169746680 hasConcept C50382708 @default.
• W2169746680 hasConcept C530470458 @default.
• W2169746680 hasConcept C55493867 @default.
• W2169746680 hasConcept C71924100 @default.
• W2169746680 hasConcept C86803240 @default.
• W2169746680 hasConceptScore W2169746680C118131993 @default.
• W2169746680 hasConceptScore W2169746680C121608353 @default.
• W2169746680 hasConceptScore W2169746680C125555471 @default.
• W2169746680 hasConceptScore W2169746680C126322002 @default.
• W2169746680 hasConceptScore W2169746680C143998085 @default.
• W2169746680 hasConceptScore W2169746680C170493617 @default.
• W2169746680 hasConceptScore W2169746680C207103383 @default.
• W2169746680 hasConceptScore W2169746680C2775960820 @default.
• W2169746680 hasConceptScore W2169746680C2781197716 @default.
• W2169746680 hasConceptScore W2169746680C2908728163 @default.
• W2169746680 hasConceptScore W2169746680C44249647 @default.
• W2169746680 hasConceptScore W2169746680C502942594 @default.
• W2169746680 hasConceptScore W2169746680C50382708 @default.
• W2169746680 hasConceptScore W2169746680C530470458 @default.
• W2169746680 hasConceptScore W2169746680C55493867 @default.
• W2169746680 hasConceptScore W2169746680C71924100 @default.
• W2169746680 hasConceptScore W2169746680C86803240 @default.
• W2169746680 hasFunder F4320320997 @default.
• W2169746680 hasIssue "4" @default.

• next